A Study to Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AMG 592 in Healthy Participants
Clinical trial NCT05873907 · COMPLETED
Trial details
- NCT number
- NCT05873907
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-19
- Primary completion
- 2017-06-16
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.